Related Experiment Video
Updated: May 23, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Estrogen metabolites and hydrogen peroxide - Missing elements in the pathophysiology and possible treatment of
Zofia Winczewska1, Agnieszka Mechlińska2, Piotr Radziwiłłowicz2
1Department of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Abstract:
The pathogenesis of depression is complex and heterogeneous, and the management of this disease remains unsatisfactory, so mechanisms and therapeutic strategies are constantly being sought. This study aimed to determine the potential role of estrogen metabolites in the pathogenesis of treatment-resistant depression (TRD) based on the determination of concentrations of estrogens and their metabolites and hydrogen peroxide (H202) in the biological material of patients with TRD. In this study, we observed for the first time an association between unbalanced estrogen metabolism and elevated H202 levels in TRD patients. Reduced concentrations of 2-methoxyestradiol (2-ME2), 17α-estradiol (α-E2) and 17β-estradiol (β-E2) may be due to abnormal estrogen metabolism toward neurotoxic semiquinones and quinones which are a potential as yet undescribed mechanism responsible for generating oxidative stress (OS) in TRD.
Insights
Estrogen metabolism imbalances and elevated hydrogen peroxide (H2O2) are linked to treatment-resistant depression (TRD). Reduced estrogen metabolites may contribute to oxidative stress in TRD pathogenesis.
Area of Science:
- Neuroscience
- Endocrinology
- Biochemistry
Background:
- Depression pathogenesis is complex and management remains challenging.
- Novel therapeutic strategies and mechanisms for treatment-resistant depression (TRD) are needed.
Purpose of the Study:
- To investigate the role of estrogen metabolites in TRD pathogenesis.
- To determine concentrations of estrogens, their metabolites, and hydrogen peroxide (H2O2) in TRD patients.
Main Methods:
- Measurement of estrogen and metabolite concentrations in biological samples from TRD patients.
- Quantification of hydrogen peroxide (H2O2) levels in the same patient cohort.
Main Results:
- First-time observed association between unbalanced estrogen metabolism and elevated H2O2 in TRD.
- Reduced concentrations of 2-methoxyestradiol (2-ME2), 17α-estradiol (α-E2), and 17β-estradiol (β-E2) noted.
- Abnormal estrogen metabolism may lead to neurotoxic semiquinones and quinones.
Conclusions:
- Unbalanced estrogen metabolism and increased oxidative stress are implicated in TRD.
- Potential novel mechanism involving neurotoxic metabolites contributing to oxidative stress in TRD identified.
Related Concept Videos
Peroxisomes
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Depression: Overview
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...

